Anti-MRSA mechanism of spirostane saponin in Rohdea pachynema F.T.Wang & tang

J Ethnopharmacol. 2024 Sep 15:331:118327. doi: 10.1016/j.jep.2024.118327. Epub 2024 May 13.

Abstract

Ethnopharmacology relevance: Rohdea pachynema F.T.Wang & Tang (R. pachynema), is a traditional folk medicine used for the treatment of stomach pain, stomach ulcers, bruises, and skin infections in China. Some of the diseases may relate to microbial infections in traditional applications. However few reports on its antimicrobial properties and bioactive components.

Aim of the study: To identify its bioactive constituents against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo, and its mechanism.

Materials and methods: The anti-MRSA ingredient 6α-O-[β-D-xylopyranosyl-(1 → 3)-β-D-quinovopyranosyl]-(25S)-5α-spirostan-3β-ol (XQS) was obtained from R. pachynema by phytochemical isolation. Subsequently, XQS underwent screening using the broth microdilution method and growth inhibition curves to assess its antibacterial activity. The mechanism of XQS was evaluated by multigeneration induction, biofilm resistance assay, scanning electron microscopy, transmission electron microscopy, and metabolomics. Additionally, a mouse skin infection model was established in vivo.

Results: 26 compounds were identified from the R. pachynema, in which anti-MRSA spirostane saponin (XQS) was reported for the first time with a minimum inhibitory concentration (MIC) of 8 μg/mL. XQS might bind to peptidoglycan (PGN) of the cell wall, phosphatidylglycerol (PG), and phosphatidylethanolamine (PE) of the cell membrane, then destroying the cell wall and the cell membrane, resulting in reduced membrane fluidity and membrane depolarization. Furthermore, XQS affected MRSA lipid metabolism, amino acid metabolism, and ABC transporters by metabolomics analysis, which targeted cell walls and membranes causing less susceptibility to drug resistance. Furthermore, XQS (8 mg/kg) recovered skin wounds in mice infected by MRSA effectively, superior to vancomycin (8 mg/kg).

Conclusions: XQS showed anti-MRSA bioactivity in vitro and in vivo, and its mechanism association with cell walls and membranes was reported for the first, which supported the traditional uses of R. pachynema and explained its sensitivity to MRSA.

Keywords: Anti-MRSA mechanisms; Metabolomics; Rohdea pachynema; Spirostane saponins.

MeSH terms

  • Animals
  • Anti-Bacterial Agents* / isolation & purification
  • Anti-Bacterial Agents* / pharmacology
  • Biofilms / drug effects
  • Female
  • Fishes
  • Male
  • Methicillin-Resistant Staphylococcus aureus* / drug effects
  • Mice
  • Microbial Sensitivity Tests*
  • Saponins* / isolation & purification
  • Saponins* / pharmacology
  • Spirostans / isolation & purification
  • Spirostans / pharmacology
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology

Substances

  • Anti-Bacterial Agents
  • Saponins
  • Spirostans